Syngene International Limited

NSEI:SYNGENE Stock Report

Market Cap: ₹339.8b

Syngene International Future Growth

Future criteria checks 3/6

Syngene International is forecast to grow earnings and revenue by 19.3% and 16% per annum respectively. EPS is expected to grow by 19.2% per annum. Return on equity is forecast to be 13.4% in 3 years.

Key information

19.3%

Earnings growth rate

19.2%

EPS growth rate

Life Sciences earnings growth22.8%
Revenue growth rate16.0%
Future return on equity13.4%
Analyst coverage

Good

Last updated28 Oct 2024

Recent future growth updates

Recent updates

Why Syngene International's (NSE:SYNGENE) Shaky Earnings Are Just The Beginning Of Its Problems

Oct 31
Why Syngene International's (NSE:SYNGENE) Shaky Earnings Are Just The Beginning Of Its Problems

Syngene International Limited's (NSE:SYNGENE) Popularity With Investors Is Under Threat From Overpricing

Jul 16
Syngene International Limited's (NSE:SYNGENE) Popularity With Investors Is Under Threat From Overpricing

These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely

Mar 28
These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely

Do Syngene International's (NSE:SYNGENE) Earnings Warrant Your Attention?

Feb 14
Do Syngene International's (NSE:SYNGENE) Earnings Warrant Your Attention?

Earnings Not Telling The Story For Syngene International Limited (NSE:SYNGENE)

Jan 19
Earnings Not Telling The Story For Syngene International Limited (NSE:SYNGENE)

Is Syngene International (NSE:SYNGENE) A Risky Investment?

Nov 19
Is Syngene International (NSE:SYNGENE) A Risky Investment?

Is Now The Time To Put Syngene International (NSE:SYNGENE) On Your Watchlist?

Nov 01
Is Now The Time To Put Syngene International (NSE:SYNGENE) On Your Watchlist?

Syngene International (NSE:SYNGENE) Seems To Use Debt Rather Sparingly

Aug 07
Syngene International (NSE:SYNGENE) Seems To Use Debt Rather Sparingly

These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely

Apr 28
These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely

Here's Why We Think Syngene International (NSE:SYNGENE) Is Well Worth Watching

Apr 06
Here's Why We Think Syngene International (NSE:SYNGENE) Is Well Worth Watching

Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?

Jan 04
Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?

Syngene International (NSE:SYNGENE) Has A Pretty Healthy Balance Sheet

Dec 08
Syngene International (NSE:SYNGENE) Has A Pretty Healthy Balance Sheet

Is Syngene International (NSE:SYNGENE) Using Too Much Debt?

Aug 28
Is Syngene International (NSE:SYNGENE) Using Too Much Debt?

Syngene International Limited (NSE:SYNGENE) Shares Could Be 22% Above Their Intrinsic Value Estimate

Aug 10
Syngene International Limited (NSE:SYNGENE) Shares Could Be 22% Above Their Intrinsic Value Estimate

These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Reasonably Well

May 10
These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Reasonably Well

Does Syngene International (NSE:SYNGENE) Have A Healthy Balance Sheet?

Feb 02
Does Syngene International (NSE:SYNGENE) Have A Healthy Balance Sheet?

Earnings and Revenue Growth Forecasts

NSEI:SYNGENE - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202751,4207,8894,21612,7506
3/31/202644,4106,7253,48611,3998
3/31/202538,0085,6153,8649,6008
9/30/202434,5114,8194,7409,589N/A
6/30/202434,7024,923N/AN/AN/A
3/31/202434,8865,1005,31310,421N/A
12/31/202335,6615,002N/AN/AN/A
9/30/202334,9854,9844,70610,290N/A
6/30/202333,5654,839N/AN/AN/A
3/31/202331,9294,6443,0528,235N/A
12/31/202229,5664,334N/AN/AN/A
9/30/202228,1214,2771,0835,898N/A
6/30/202226,5423,924N/AN/AN/A
3/31/202226,0423,9581,0515,806N/A
12/31/202125,0474,086N/AN/AN/A
9/30/202124,4784,0682,1026,566N/A
6/30/202123,5724,242N/AN/AN/A
3/31/202121,8434,0492,5477,012N/A
12/31/202021,3303,645N/AN/AN/A
9/30/202020,6763,5411,2176,318N/A
6/30/202020,1263,981N/AN/AN/A
3/31/202020,1194,1213406,771N/A
12/31/201919,3853,920N/AN/AN/A
9/30/201918,8653,8721,2577,549N/A
6/30/201918,4053,374N/AN/AN/A
3/31/201918,2563,3164716,304N/A
12/31/201817,0083,160N/AN/AN/A
9/30/201816,2143,110N/AN/AN/A
6/30/201815,3803,096N/AN/AN/A
3/31/201814,2313,054N/A4,462N/A
12/31/201713,0532,993N/AN/AN/A
9/30/201712,4972,917N/AN/AN/A
6/30/201712,1752,895N/AN/AN/A
3/31/201712,0092,873N/A3,977N/A
12/31/201612,4112,682N/AN/AN/A
9/30/201611,8942,606N/AN/AN/A
6/30/201611,4792,344N/AN/AN/A
3/31/201611,0702,408N/A3,081N/A
12/31/201510,2352,103N/AN/AN/A
9/30/20159,7131,964N/AN/AN/A
6/30/20159,0171,843N/AN/AN/A
3/31/20158,5991,750N/A185N/A
3/31/20146,9951,339N/A2,995N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SYNGENE's forecast earnings growth (19.3% per year) is above the savings rate (6.7%).

Earnings vs Market: SYNGENE's earnings (19.3% per year) are forecast to grow faster than the Indian market (18.1% per year).

High Growth Earnings: SYNGENE's earnings are forecast to grow, but not significantly.

Revenue vs Market: SYNGENE's revenue (16% per year) is forecast to grow faster than the Indian market (10.5% per year).

High Growth Revenue: SYNGENE's revenue (16% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: SYNGENE's Return on Equity is forecast to be low in 3 years time (13.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y